当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 现金流量表

东方生物

(688298)

  

流通市值:48.93亿  总市值:48.93亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金686,034,931.2459,201,097.93244,090,639.16849,074,992.51
  收到的税费返还33,046,574.5222,165,227.6510,770,706.2749,586,315.9
  收到其他与经营活动有关的现金72,722,726.2539,005,893.9721,161,222.53239,285,334.38
  经营活动现金流入小计791,804,231.97520,372,219.55276,022,567.961,137,946,642.79
  购买商品、接受劳务支付的现金327,921,176.02219,447,428.8105,619,754.22585,681,072.37
  支付给职工以及为职工支付的现金356,587,056.88247,738,027.65128,596,882.82529,610,957.96
  支付的各项税费34,469,429.6426,030,220.6514,221,291.2835,996,630.74
  支付其他与经营活动有关的现金227,459,359.26150,427,133.4381,873,249.81334,984,837.04
  经营活动现金流出小计946,437,021.8643,642,810.53330,311,178.131,486,273,498.11
  经营活动产生的现金流量净额-154,632,789.83-123,270,590.98-54,288,610.17-348,326,855.32
二、投资活动产生的现金流量:
  收回投资收到的现金500,694,127.14263,200,517.99163,727,360996,479,507.58
  取得投资收益收到的现金1,665,124.38818,920.01668,546.1430,259,041.88
  处置固定资产、无形资产和其他长期资产收回的现金净额313,562.45300,142.4554,449.457,514,070.09
  收到的其他与投资活动有关的现金3,778,942,720.642,686,177,147.781,301,988,103.733,915,211,953.99
  投资活动现金流入小计4,281,615,534.612,950,496,728.231,466,438,459.324,949,464,573.54
  购建固定资产、无形资产和其他长期资产支付的现金269,792,868.01207,589,449.21152,705,711.63924,094,818.92
  投资支付的现金334,307,881.48380,366,804.87309,503,360318,224,495.4
  取得子公司及其他营业单位支付的现金-00320,760,237.18
  支付其他与投资活动有关的现金3,991,221,500.922,159,142,202.611,294,856,303.14,056,534,814.46
  投资活动现金流出小计4,595,322,250.412,747,098,456.691,757,065,374.735,619,614,365.96
  投资活动产生的现金流量净额-313,706,715.8203,398,271.54-290,626,915.41-670,149,792.42
三、筹资活动产生的现金流量:
  吸收投资收到的现金-00360,000
  其中:子公司吸收少数股东投资收到的现金---360,000
  取得借款收到的现金346,000,000271,000,000239,000,000300,750,000
  收到其他与筹资活动有关的现金2,281,234.100-
  筹资活动现金流入小计348,281,234.1271,000,000239,000,000301,110,000
  偿还债务支付的现金500,000,000406,000,000364,000,000431,700,000
  分配股利、利润或偿付利息支付的现金5,600,403.213,593,697.652,046,598.6116,631,227.38
  其中:子公司支付给少数股东的股利、利润-0--
  支付其他与筹资活动有关的现金63,394,252.799,773,839.092,936,600.39304,516,084.05
  筹资活动现金流出小计568,994,656419,367,536.74368,983,199752,847,311.43
  筹资活动产生的现金流量净额-220,713,421.9-148,367,536.74-129,983,199-451,737,311.43
四、汇率变动对现金及现金等价物的影响-2,910,406.581,645,378.843,253,774.5151,885,915.88
五、现金及现金等价物净增加额-691,963,334.11-66,594,477.34-471,644,950.07-1,418,328,043.29
  加:期初现金及现金等价物余额1,510,275,298.881,510,275,298.881,510,275,298.882,928,603,342.17
  期末现金及现金等价物余额818,311,964.771,443,680,821.541,038,630,348.811,510,275,298.88
补充资料:
  净利润--174,059,798.07--568,822,462.49
  资产减值准备-13,924,362.69-175,703,291.62
  固定资产和投资性房地产折旧-46,512,213.64-100,791,302.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-46,512,213.64-100,791,302.83
  无形资产摊销-39,389,221.51-80,547,339.31
  长期待摊费用摊销-10,992,251.1-21,985,730.19
  处置固定资产、无形资产和其他长期资产的损失--1,741,743.14--987,647.61
  固定资产报废损失-80,221.82-171,750.36
  公允价值变动损失--4,992,565.99--10,654,769.31
  财务费用--13,603,947.38--45,776,256.97
  投资损失--3,484,332.15--29,776,712.67
  递延所得税--252,839.01--22,479,345.91
  其中:递延所得税资产减少--129,707.65--22,675,987.71
    递延所得税负债增加--123,131.36-196,641.8
  存货的减少--18,012,620.13-1,911,558
  经营性应收项目的减少--42,631.99--109,368,761.14
  经营性应付项目的增加--26,938,579.16--11,523,909.31
  其他---15,782,208.33
  现金的期末余额-1,443,680,821.54-1,510,275,298.88
  减:现金的期初余额-1,510,275,298.88-2,928,603,342.17
  现金及现金等价物的净增加额--66,594,477.34--1,418,328,043.29
公告日期2025-10-312025-08-292025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑